Physician

Timothy A Lucas, MD

According to 2025 Medicare claims, Timothy Lucas, MD (NPI: 1598723629) practices pulmonary disease in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is ALTOONA LUNG SPECIALISTS (NPI: 1457394835; TIN: 251384796) and primary practice location at 16602-4165. Lucas is affiliated with the AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Lucas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 696 traditional Medicare patients, billed 2,777 HCPCS/CPT codes, and received $201,651 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,559 prescription claims across 371 beneficiaries totaling $1,801,484 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,505 claims. Open Payments data shows 123 records totaling $3,230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $898,495 to $1,801,484. For DME billing, reported payments rose steadily, from $117,481 to $163,037.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	524	2,450	$135,101
2016	575	2,277	$134,519
2017	621	2,196	$148,522
2018	632	2,225	$152,057
2019	603	1,929	$131,199
2020	550	1,526	$108,838
2021	560	1,909	$130,139
2022	532	1,606	$111,581
2023	670	2,800	$194,673
2024	696	2,777	$201,651

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	259	1,835	$898,495
2016	261	1,862	$1,042,578
2017	288	2,009	$1,164,965
2018	308	2,251	$1,435,516
2019	335	2,381	$1,955,529
2020	342	2,551	$2,302,801
2021	317	2,401	$2,306,609
2022	325	2,288	$2,275,404
2023	366	2,433	$1,910,869
2024	371	2,559	$1,801,484

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	694	1,805	$113,925
2016	1,212	3,042	$103,371
2017	1,591	4,285	$112,861
2018	1,657	4,018	$117,267
2019	1,850	4,687	$148,552
2020	1,956	5,089	$224,678
2021	1,833	4,621	$222,110
2022	1,647	3,787	$192,008
2023	1,522	3,669	$167,195
2024	1,444	3,505	$167,943

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	80	83	$97
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	238	938	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	361	483	$82
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	165	439	$59
94010	Test to measure expiratory airflow and volume	91	95	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	560	22,980	$470,861
Prolastin C	Alpha-1-Proteinase Inhibitor	43	1,176	$438,048
Xywav	Sodium,calcium,mag,pot Oxybate	11	330	$216,151
Tezspire	Tezepelumab-Ekko	21	700	$112,940
Breo Ellipta	Fluticasone/Vilanterol	162	6,420	$81,443

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	117	245	$22,130
A7031	Face mask interface, replacement for full face mask, each	N	100	223	$17,417
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	22	167	$13,249
E0601	Continuous positive airway pressure (cpap) device	Y	70	387	$13,160
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,253

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	123	$3,230	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Timothy A. Lucas, MD?

Tedicare shows public-source Medicare data for Timothy A. Lucas, MD (NPI 1598723629), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy A. Lucas, MD have ACO affiliation data?

Timothy A. Lucas, MD is shown with ACO affiliation data for AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Timothy A. Lucas, MD?

Timothy A. Lucas, MD is linked to ALTOONA LUNG SPECIALISTS (billing NPI 1457394835) in the available physician profile data.

Does Timothy A. Lucas, MD have Open Payments data?

Timothy A. Lucas, MD has 123 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.